Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
NCT06641362
This study is recruiting at 7 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Bradycardia
- Heart Failure
- Ventricular Dysfunction
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- VDI Technologies
- Last updated on ClinicalTrials.gov
- May 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 2
- Peak Heart and Vascular · Avondale, AZ
- Banner Medical Center · Mesa, AZ
Illinois · 1
- University of Chicago · Chicago, IL
Minnesota · 1
- Mayo Clinic · Rochester, MN
Ohio · 1
- Ohio State University · Columbus, OH
Texas · 1
- Baylor College of Medicine · Houston, TX
Virginia · 1
- University of Virginia · Charlottesville, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.